Abstract:Within the GBM microenvironment, distinct micro-niches arise from independent cancer cell lineages with unique metabolic needs, characterized as Fast Cycling Cells (FCCs) and Slow Cycling Cells (SCCs). FCCs preferentially utilize aerobic glycolysis for energy, whereas treatment-resistant SCCs depend on lipid metabolism. Our study decodes the molecular and spatial heterogeneity within the GBM microenvironment, focusing on the dichotomy of immune infiltrates and the metabolic interactions between SCCs and the immune compartment in human GBM patients. We performed spatial transcriptomics and proteomics combined with geospatially resolved single-cell neighborhood analysis of IHC-stained GBM tissues using CellProfiler and the SNAQ algorithm that we developed to investigate the specific immune microenvironment of SCCs and FCCs. Holotomography and fluorescence-based time-lapse imaging coupled with flow cytometry were used to study lipid transfer between immune cells and GBM cells. Finally, the effects of pharmacological and genetic targeting of lipid transfer were investigated both in vitro and in vivo. Our study establishes a connection between spatial metabolic heterogeneity and immune diversity, highlighting how specific tumor cell lineages correlate with characteristic immune micro-niches. In particular, SCCs exploit the metabolic properties of recruited immunosuppressive myeloid-derived cells, which metabolically support tumor cells by facilitating lipid transport and supporting SCC metabolism. Our results show that inhibiting lipid transfer affect SCCs, remodels the immune microenvironment, delays tumor growth and improves disease outcome. Our study also demonstrates a correlation between predicted sensitivity to lipid-modifying drugs, such as statins, and the SCC phenotype. This correlation could enable stratification and selection of patients most likely to benefit from such treatments. This study establishes critical connections between the TME, cellular metabolism, anti-tumor immunity, and treatment vulnerabilities. Our research provides novel insights into how metabolic exchanges contribute to tumor progression and suggests that targeting metabolic interactions could be an effective therapeutic strategy for GBM.

Integrated combinatorial functional genomics and spatial transcriptomics of tumors decodes genotype to phenotype relationships

Functional variomics and network perturbation: connecting genotype to phenotype in cancer

Pheno-Seq – Linking 3D Phenotypes of Clonal Tumor Spheroids to Gene Expression

pheno-seq – linking morphological features to gene expression in 3D cell culture systems

Deciphering functional tumor–immune crosstalk through highly multiplexed imaging and deep visual proteomics

An integrative spatial multi-omic workflow for unified analysis of tumor tissue

Deciphering Colorectal Cancer-Hepatocyte Interactions: A Multiomic Platform for Interrogation of Metabolic Crosstalk in the Liver-Tumor Microenvironment

Precision unveiled: Synergistic genomic landscapes in breast cancer—Integrating single‐cell analysis and decoding drug toxicity for elite prognostication and tailored therapeutics

An Integrative -omics Approach to Identify Functional Sub-Networks in Human Colorectal Cancer

Combining Scalable Organ Chip Platform with Deep Learning-Based Imaging Analysis for Cancer Therapeutic Screening

Spatial genomics maps the structure, nature and evolution of cancer clones

In vivo functional screening for systems-level integrative cancer genomics

Toward an integrated map of genetic interactions in cancer cells

Spatially resolved multi-omics highlights cell-specific metabolic remodeling and interactions in gastric cancer

Tmic-52. Decoding Metabolic Interactions In Glioblastoma Tumor Microenvironment Through Comprehensive Spatial Transcriptomic And Proteomic Analysis

An integrated tumor, immune and microbiome atlas of colon cancer

High resolution mapping of the tumor microenvironment using integrated single-cell, spatial and in situ analysis

A new spatial multi-omics approach to deeply characterize human cancer tissue using a single tissue section

Detecting phenotype-specific tumor microenvironment by merging bulk and single cell expression data to spatial transcriptomics

Multifactorial Deep Learning Reveals Pan-Cancer Genomic Tumor Clusters with Distinct Immunogenomic Landscape and Response to Immunotherapy.

Spatially defined multicellular functional units in colorectal cancer revealed from single cell and spatial transcriptomics